Galetin 3,6-dimethyl ether (FGAL), a flavonoid from the aerial parts of Piptadenia stipulacea (Benth.) Ducke, was found to exert a relaxant effect on carbachol (CCh)-pre-contracted guinea-pig trachea. Based on cumulative concentration-response curves to CCh, FGAL antagonized muscarinic receptors pseudo-irreversibly and noncompetitively, since it inhibited and shifted these curves towards higher concentrations in a nonparallel manner. In addition, FGAL was more potent in relaxing contractions induced by 18 mM as compared to 60 mM KCl (pD 2 = 5.50 ± 0.36 and 4.80 ± 0.07, respectively), indicating the participation of K + channels. In the presence of 10 mM tetraethylammonium (TEA + ) chloride, a nonselective K + channel blocker, the relaxant potency of FGAL was reduced (from pD 2 = 5.12 ± 0.07 to 4.87 ± 0.02). Among several selective blockers of K + channel subtypes, only apamin, an SK Ca (small-conductance Ca 2+ -activated K + channels) blocker, attenuated the relaxant potency of FGAL (pD 2 = 4.85 ± 0.06), suggesting SK Ca activation. FGAL was equipotent in relaxing trachea contracted by 60 mM KCl (pD 2 = 4.80 ± 0.07) or 10 −6 M CCh (pD 2 = 5.02 ± 0.07), suggesting Ca V (voltage-gated calcium channel), but not ROCs (receptor-operated calcium channels) participation. Furthermore, aminophylline-induced relaxation (pD 2 = 4.12 ± 0.06) was potentiated around 4-fold (pD 2 = 4.80 ± 0.44) in the presence of FGAL. Moreover, forskolininduced relaxation (pD 2 = 6.51 ± 0.06) was potentiated around 2.5-fold (pD 2 = 6.90 ± 0.05) by FGAL. Conversely, sodium nitroprusside-induced relaxation was unaffected, indicating that the AC/cAMP/PKA pathway, but not the NO pathway, may be modulated by the flavonoid. These results suggest that, in guinea-pig trachea, FGAL induces relaxation by pseudo-irreversible noncompetitive antagonism on muscarinic receptors, modulation of K + and Ca 2+ channels, as well as activation of the AC/cAMP/PKA pathway.
Introduction
Piptadenia stipulacea (Benth.) Ducke (Fabaceae) is a tree of the Brazilian caatinga (Albuquerque and Andrade, 2002) popularly known as "Jurema Branca" (Fabricante and Andrade, 2007) , "Jurema malícia-daserra", "Carcará", and "Calumbi" (Florentino et al., 2007) . In folk medicine, the decoction or tincture of its bark and leaves are used to treat wounds (Albuquerque and Andrade, 2002) and as healing agents (Bezerra et al., 2011) .
The chloroform phase of the crude ethanolic extract from the aerial parts of P. stipulacea provides three flavonoids: santin, demethoxycentaureidin, and galetin 3,6-dimethyl ether (FGAL) (Fig. 1) , whose structures were identified by 1 H and 13 C NMR (one- and two-dimensional) spectroscopy and by comparison with literature data (Queiroz et al., 2010) .
Flavonoids exert several pharmacological effects: antioxidant and anti-inflammatory (Hämäläinen et al., 2007) , antineoplastic (Izzo, 1996) , vascular protective (Beretz and Cazenave, 1988) , and relaxant on ileum (Macander, 1986; Lima et al., 2005; Verspohl et al., 2013) , rat aorta (Ajay et al., 2003; Lapa et al., 2011; Avila-Villarreal et al., 2013) , and guinea-pig trachea (Lima et al., 2011; Liu et al., 2008) . Some pharmacological activities have been described for FGAL, such as antiviral (Edwards et al., 2010) , used in the treatment of skin (Rosenbloom, 2003) and peripheral vascular and neural diseases (Rosenbloom, 2004) , as well as anticancer activity (Rosenbloom, 2006) , and antinociceptive and anti-inflammatory activities in mice (Queiroz et al., 2010) .
Recently, it was demonstrated that FGAL exhibits a nonselective spasmolytic activity on guinea-pig ileum and trachea and rat uterus and aorta (Macêdo et al., 2011) . Therefore, in the present study we aimed to investigate the mechanism underlying the FGALrelaxant activity in guinea-pig trachea thereby contributing to the discovery of natural compounds of medicinal interest.
Materials and Methods

Drugs and chemicals
FGAL was obtained as previously described (Queiroz et al., 2010) . Briefly, aerial parts of the species were milled and extracted with ethanol at room temperature, obtaining the crude ethanol extract, which yielded the n-hexane, chloroform, ethyl acetate, and methanol phases after liquid/liquid extraction. The chloroform phase was subjected to column chromatography in normal phase providing three flavonoids: santin, demethoxycentaureidin, and galetin 3,6-dimethyl ether (FGAL). 4-Aminopyridine (4-AP), aminophylline, apamin, BaCl 2 , Cremophor EL ™ , forskolin, glibenclamide, sodium nitroprusside (SNP), and tetraethylammonium (TEA + ) chloride were purchased from Sigma-Aldrich (St. Louis, MO, USA). Carbamylcholine hydrochloride (carbachol, CCh) was purchased from Merck (New York, NY, USA). All substances were dissolved in distilled water, except glibenclamide, which was dissolved in ethanol (95 %), and FGAL, that was solubilized in Cremophor EL ™ (3 %) and distilled water at the concentration of 10 −2 M, being again diluted in distilled water as required for each experimental protocol. The final content of Cremophor EL ™ in the organ solution never exceeded 0.01 % (v/v).
Animal and tissue preparation
Adult guinea-pigs (Cavia porcellus) from the Bioterium Prof. Thomas George of the Centro de Biotecnologia (CBiotec)/UFPB (João Pessoa, Brazil), weighing 300 -500 g, were used. Actions on reducing pain, stress, and any suffering have been taken in accordance with the local ethical guidelines for animal usage. All experimental procedures had been approved and were performed in accordance with the Animal Research Ethic Committee of CBiotec/UFPB guidelines (protocol CEPA 0203/11). The trachea was dissected and immediately removed from the animals, cleaned of connective tissue, cut into transverse strips of three adjacent cartilage rings (3 -4 mm wide), and suspended under an 1-g load in organ baths at 37 • C containing Krebs solution (in mM) [NaCl (118.0), KCl (4.6), MgSO 4 · 7H 2 O (5.7), KH 2 PO 4 · H 2 O (1.1), CaCl 2 · H 2 O (2.5), NaHCO 3 (25.0), and glucose (11.0)]. The rings were continuously bubbled with carbogen mixture (95 % O 2 and 5 % CO 2 ).
Measurement of contractile responses
Isometric tensions were recorded using an isometric transducer coupled to an amplifier (World Precision Instruments, Sarasota, FL, USA). Before the experiments started, the tracheal ring preparations were stabilized for 60 min, while the bathing solution was removed and replaced with fresh Krebs solution every 20 min; changes in resting tension were adjusted back to 1 g weight. In order to verify antagonism of muscarinic receptors, the effect of FGAL was evaluated in cumulative concentration-response curves to CCh. To evaluate the participation of K + channels, a contraction was induced with 18 or 60 mM KCl and, at the tonic phase of the contraction, FGAL was cumulatively added to obtain a concentration-response relaxation curve. The relaxant effect induced by FGAL was expressed as the reverse percentage of the initial contraction elicited by 18 or 60 mM KCl. To investigate the K + channel subtypes, the following blockers were used: TEA + (10 mM), a nonselective K + channel blocker (Niu et al., 2008) ; TEA + (1 mM), a selective blocker of large-conductance Ca 2+ -activated K + channels (BK Ca ) (Niu et al., 2008) ; glibenclamide (3 · 10 −6 M), a selective blocker of ATP-sensitive K + channels (K ATP ) (Mishra and Aaronson, 1999) ; 4-AP (3 · 10 −3 M), a selective blocker of voltage-gated K + channels (K V ) (Cole et al., 1996) ; BaCl 2 (10 −4 M), a selective blocker of inward rectifier K + channels (K ir ) (Orie et al., 2006) ; and apamin (5 · 10 −8 M), a selective blocker of small-conductance Ca 2+ -activated K + channels (SK Ca ) ( Van-Der-Staay et al., 1999) . To verify the participation of voltage-dependent calcium channels (Ca V ) and/or receptor-operated calcium channels (ROCs) in the relaxant action of FGAL, its relaxant potency was compared with that achieved when the trachea was contracted by 10 −6 M CCh and by 60 mM KCl. The involvement of cyclic nucleotide phosphodiesterases (PDEs) was investigated using aminophylline, a nonselective inhibitor of PDEs (Hirsh et al., 2004) . In addition, forskolin was employed as an adenylate cyclase activator (Seamon and Daly, 1981) and SNP as a nitric oxide (NO) donor (Murad et al., 1978) .
Statistical analysis
All data are expressed as means ± SEM. The negative decadic logarithm of the FGAL concentration that produced a half-maximal response (pD 2 , also denoted as pEC 50 ) was used as the parameter for the potency, and the maximum effect (E max ) was the parameter of efficacy. Statistical comparisons were made by Student's t-test, for single comparisons, and one-way ANOVA followed by Bonferroni's test, for multiple comparisons. The differences were considered significant when p < 0.05.
Results
Effect of FGAL on cumulative concentration-response curves to CCh
To verify the antagonism exerted by FGAL (Fig. 1 ) on muscarinic receptors, two similar cumu- 1.1 ± 0.1 · 10 −6 100 3 · 10 −5
1.4 ± 0.1 · 10 −6 83.6 ± 6.4 10 −4 8.9 ± 1.1 · 10 −6 * * * 29.6 ± 5.6 * * * 3 · 10 −4 N/A 0 * * * lative concentration-response curves to CCh (10 −9 to 10 −4 M) were obtained (control). Then, after a 15-min incubation of different preparations with increasing FGAL concentrations, a third cumulative concentration-response curve to CCh was obtained. Each preparation was exposed to a single FGAL concentration. The maximum amplitude was designated 100 % (control), and all contractions in the presence of FGAL were related to it. The inhibitory effect of FGAL was evaluated based on the EC 50 and the E max values of CCh in both the absence (control) and presence of FGAL (Fig. 2 , Table I ).
Effect of FGAL on guinea-pig trachea pre-contracted by 18 or 60 mM KCl
First, we determined whether FGAL activates K + channels or blocks Ca 2+ channels. For this, the FGAL-induced relaxation was observed for contractions induced by KCl. FGAL relaxed the trachea pre-contracted by 18 mM (pD 2 = 5.50 ± 0.36) or 60 mM KCl (pD 2 = 4.80 ± 0.07). The E max (100 %) was achieved at concentrations of 3 · 10 −5 and 10 −4 M FGAL, respectively. FGAL was 2.3-fold more potent to relax the trachea pre-contracted by 18 mM KCl (p < 0.001) than by 60 mM KCl (Fig. 3) . To assess whether K + channels participate in FGAL-mediated relaxation of the guinea-pig trachea, preparations were pre-incubated for 20 min in TEA + (10 mM), a nonselective K + channel blocker, and FGAL was then cumulatively added. The relaxant potency of FGAL was attenuated in a significant manner (p < 0.05), according to the pD 2 value that changed from 5.12 ± 0.07 (control) to 4.87 ± 0.02 in the presence of the blocker. Other K + channel subtypes were investigated using their respective selective blockers: TEA + , at 1 mM, a BK Ca blocker; glibenclamide, a K ATP blocker; BaCl 2 , a K ir blocker; and 4-AP, a K V blocker. However, the relaxant potency of FGAL was not significantly altered in the presence of any of the blockers (pD 2 = 5.31 ± 0.05, 5.25 ± 0.03, 5.28 ± 0.06, and 5.04 ± 0.06, respectively). But, interestingly, in the presence of apamin, a SK Ca blocker, the relaxant potency of FGAL was significantly attenuated (p < 0.05) (pD 2 = 4.85 ± 0.06) (Fig. 4 and Table II).
Effect of FGAL on guinea-pig trachea pre-contracted by CCh or 60 mM KCl
To verify the role of Ca V and/or ROCs in the induction of relaxation by FGAL, the flavonoid was added cumulatively after pre-contraction of the trachea by either 10 −6 M CCh or 60 mM KCl. The relaxant effects of FGAL were comparable (pD 2 = 5.12 ± 0.07 and pD 2 = 4.80 ± 0.07, respectively) (Fig. 5) .
Effects of aminophylline on guinea-pig trachea pre-contracted by CCh in both the absence and presence of FGAL
To investigate the participation of cyclic nucleotide PDEs, aminophylline (10 −10 -10 −3 M) was added cumulatively and found to relax the tracheal rings precontracted by 10 −6 M CCh in both the absence (pD 2 = 4.12 ± 0.06) and presence (pD 2 = 4.80 ± 0.44) of 10 −5 M FGAL that was added 20 min prior to the addition of aminophylline. FGAL potentiated (p < 0.05) the aminophylline-induced relaxation about 4-fold (Fig. 6) . 
Effects of forskolin on guinea-pig trachea pre-contracted by CCh in both the absence and presence of FGAL
To investigate adenylate cyclase involvement, forskolin was cumulatively added (10 −9 -10 −6 M) and found to relax the tracheal rings pre-contracted by 10 −6 M CCh in both the absence (pD 2 = 6.51 ± 0.06) and presence (pD 2 = 6.90 ± 0.05) of 10 −5 M FGAL added 20 min prior to the addition of forskolin. FGAL potentiated (p < 0.01) the forskolin-induced relaxation about 2.5-fold (Fig. 7) . 
Effects of sodium nitroprusside on guinea-pig trachea pre-contracted by CCh in both the absence and presence of FGAL
To investigate the involvement of the NO pathway, sodium nitroprusside (SNP) was cumulatively added (10 −9 -3 · 10 −5 M) and found to relax the tracheal rings pre-contracted by 10 −6 M CCh in both the absence (pD 2 = 5.77 ± 0.12) and presence (pD 2 = 5.85 ± 0.06) of 10 −5 M FGAL in an equipotent manner (Fig. 8) .
Discussion
The relaxant effect of the flavonoid galetin 3,6-dimethyl ether (FGAL) on guinea-pig trachea appears to involve a positive modulation of K + channels, in particular of the SK Ca subtype, as well as a block of Ca V , with the participation of the cyclic nucleotide PDE pathway.
In a preliminary pharmacological screening, we had previously found that FGAL causes relaxation of the CCh-pre-contracted guinea-pig trachea in an equipotent manner in denuded as well as intact epithelium (Macêdo et al., 2011) , indicating that its effect is independent of the release of epithelium-derived relaxing factors. Thus, all experiments in the present work were performed with denuded epithelium. Since FGAL caused relaxation of trachea pre-contracted by CCh, we hypothesized that the flavonoid could be acting by antagonizing muscarinic receptors. To probe this hypothesis, we examined the effect of FGAL on cumulative contractions to CCh. FGAL shifted the response curves to CCh towards higher concentrations in a nonparallel manner, resulting in reduction of E max (Fig. 2) . According to May et al. (2007) , in pseudoirreversible noncompetitive antagonism, the dissociation of the drug from the receptor occurs so slowly that its action is prolonged after its removal. In the presence of a slowly dissociating antagonist, the maximum effect of the agonist is reduced and finally abolished at higher concentrations of the antagonist. Thus, according to the curves' profile in Fig. 2 , FGAL exhibited the pharmacological profile of a pseudoirreversible noncompetitive antagonist on muscarinic receptors.
In the guinea-pig trachea, extracellular and intracellular sources of Ca 2+ are important for the development of the muscular tonus, and Ca 2+ entry into smooth muscle cells occurs by two subtypes of Ca 2+ channels, i.e. Ca V and ROCs (Evangelista et al., 2007) . Furthermore, K + channels regulate the membrane potential and cellular excitability, thereby participating in the contraction and relaxation of the smooth muscle. To determine whether FGAL could activate K + channels or block Ca 2+ channels, the trachea was pre-contracted by both a moderate and a high elevation of the extracellular K + concentration ( (Raeburn and Giembycz, 1995) . FGAL was 2.3-fold more relaxant in tracheal rings pre-contracted by 18 mM KCl, indicating that it is possibly a K + channel activator (Fig. 3) .
FGAL seems to positively modulate K + channels, resulting in hyperpolarization of the plasma membrane with subsequent Ca V blockade and then relaxation of the tracheal smooth muscle. A nonselective K + channel blocker attenuated the FGAL-relaxing effect about two-fold, supporting the participation of K + channels. Since several subtypes of these channels are expressed in the tracheal smooth muscle, such as K ATP (Teramoto, 2006) , K V (Gordienko et al., 1999) , SK Ca , BK Ca (Wei et al., 2005) , and K ir (Oonuma et al., 2002) , we used channel-selective blockers to obtain evidence for their possible involvement. Interestingly, only apamin attenuated the relaxant potency of FGAL, suggesting that the flavonoid selectively modulates SK Ca positively, thereby leading to tracheal smooth muscle relaxation (Fig. 4) . Ca V and ROCs are the channels most responsible for Ca 2+ influx into the smooth muscle, which then leads to contraction. Contraction elicited by elevated [K + ] e is due to the Ca 2+ influx mainly mediated by Ca V , while agonist-induced contraction is mainly the result of ROCs activation, with a minor participation of Ca V (Noguera et al., 1997; Morello et al., 2006) . Since FGAL relaxed guinea-pig trachea contracted by both elevated [K + ] e (60 mM KCl) and by an agonist (10 −6 M CCh) in a comparable manner, the flavonoid does not appear to activate ROCs, but rather Ca V , since the common step in the action of these contractile agents is Ca V activation. If ROCs were involved, one would expect that FGAL relaxes the CCh-induced contraction more potently, since this agonist promotes contraction by activating both ROCs and Ca V (Evangelista et al., 2007) (Fig. 5 ). An important pathway involved in smooth muscle relaxation is the cyclic nucleotide PDE pathway. cAMP and cGMP activate the protein kinases PKA and PKG, which, in turn, phosphorylate several intracellular targets, among them K + channels, eventually leading to smooth muscle relaxation. PDEs inactivate cAMP and cGMP by hydrolysis, thus interrupting this cell signaling mechanism (Lugnier, 2006) , and PDE inhibitors raise the cyclic nucleotide level and thus potentiate smooth muscle relaxation (Lugnier, 2006; Bender and Beavo, 2006) . Several flavonoids have been shown to inhibit PDEs (Rahimi et al., 2010) , e.g. isoliquiritigenin, a flavonoid (chalcone) of Glycyrrhiza glabra, relaxed guinea-pig trachea by inhibition of PDEs . Aminophylline enhanced the relaxant potency of FGAL around four-fold, indicating participation of cyclic nucleotide PDEs in the relaxant effect of FGAL on guinea-pig trachea (Fig. 6) . Interestingly, FGAL potentiated the relaxant effect of forskolin, which activates adenylate cyclase thereby increasing the cytosolic levels of cAMP (Brooker et al., 1983) , providing further evidence for the involvement of cAMP in the relaxant activity of FGAL (Fig. 7) . It is well established that SNP is a potent broncho-relaxant that stimulates soluble guanylyl cyclase and thus causes intracellular cGMP accumulation (Waldman and Murad, 1987) . FGAL did not potentiate the relaxant effect of SNP on guinea-pig trachea, indicating that the NO pathway is not involved (Fig. 8) .
Therefore, the relaxant action of FGAL on guineapig trachea involves activation of K + channels, blockade of Ca V , and participation of the nucleotide PDE pathway, particularly the AC/cAMP/PKA pathway, which possibly reduce the cytosolic Ca 2+ concentration leading to airway smooth muscle relaxation.
